How to evaluate the risk/benefit of trimodality therapy in locally advanced non-small-cell lung cancer

British Journal of Cancer

Volumn 96, Issue 10, 2007, Pages 1498-1503

  Kunitoh, H ^a   Suzuki, K ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Preoperative chemoradiotherapy; Stage III NSCLC; Superior sulcus tumour; Trimodality

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE;

ADVANCED CANCER; BRONCHOPLEURAL FISTULA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MEDIASTINUM LYMPH NODE; MICROMETASTASIS; MORBIDITY; POLYMERASE CHAIN REACTION; PREDICTION; PREOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK BENEFIT ANALYSIS; SURGICAL APPROACH; SURGICAL MORTALITY; SURGICAL TECHNIQUE;

ALGORITHMS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; EVALUATION STUDIES; HUMANS; LUNG NEOPLASMS; PULMONARY SURGICAL PROCEDURES; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT;

EID: 34248575334     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603751     Document Type: Review

References (24)

1. Albain KS, Rusch VW, Crowley JJ, Rice TW, Turrisi III AT, Weick JK, Lonchyna VA, Presant CA, McKenna RJ, Gandara DR (1995) Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 13: 1880-1892
2. Albain KS, Swann RS, Rusch VR, Turrisi AT, Shepherd FA, Smith CJ, Gandara DR, Johnson DH, Green MR, Miller RC (2005) Phase III study of concurrent chemotherapy and radiotherapy vs chemotherapy and radiotherapy followed by surgical resection for stageIIIA(pN2) non-small cell lung cancer: Outcomes update of North American Intergroup: Intergroup trial 0139. Proc Am Soc Clin Oncol 23: 624S (abstr 7014)
3. Cerfolio RJ, Bryant AS, Spencer SA, Bartolucci AA (2005) Pulmonary resection after high-dose and low-dose chest irradiation. Ann Thorac Surg 80: 1224-1230; discussion 1230
4. Choi NC, Carey RW, Daly W, Mathisen D, Wain J, Wright C, Lynch T, Grossbard M, Grillo H (1997) Potential impact on survival of improved tumour downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer. J Clin Oncol 15: 712-722
5. Daly BD, Fernando HC, Ketchedjian A, Dipetrillo TA, Kachnic LA, Morelli DM, Shemin RJ (2006) Pneumonectomy after high-dose radiation and concurrent chemotherapy for nonsmall cell lung cancer. Ann Thorac Surg 82: 227-231
6. Depierre A, Milleron B, Moro-Sibilot D, Chevret S, Quoix E, Lebeau B, Braun D, Breton JL, Lemarie E, Gouva S, Paillot N, Brechot JM, Janicot H, Lebas FX, Terrioux P, Clavier J, Foucher P, Monchatre M, Coetmeur D, Level MC, Leclerc P, Blanchon F, Rodier JM, Thiberville L, Villeneuve A, Westeel V, Chastang C (2002) Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer. J Clin Oncol 20: 247-253
7. Deslauriers J, Gregoire J, Jacques LF, Piraux M, Guojin L, Lacasse Y (2004) Sleeve lobectomy vs pneumonectomy for lung cancer: a comparative analysis of survival and sites or recurrences. Ann Thorac Surg 77: 1152-1156
8. Deutsch M, Crawford J, Leopold K, Wolfe W, Foster W, Herndon J, Blackwell S, Yost R (1994) Phase II study of neoadjuvant chemotherapy and radiation therapy with thoracotomy in the treatment of clinically staged IIIA non-small cell lung cancer. Cancer 74: 1243-1252
9. Dillman RO, Herndon J, Seagren SL, Eaton Jr WL, Green MR (1996) Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. J Natl Cancer Inst 88: 1210-1215
10. Doddoli C, Thomas P, Thirion X, Seree Y, Giudicelli R, Fuentes P (2001) Postoperative complications in relation with induction therapy for lung cancer. Eur J Cardiothorac Surg 20: 385-390
11. Douillard JY, Rosell R, De Lena M, Carpagnano F, Ramlau R, Gonzales-Larriba JL, Grodzki T, Pereira JR, Le Groumellec A, Lorusso V, Clary C, Torres AJ, Dahabreh J, Souquet PJ, Astudillo J, Fournel P, Artal-Cortes A, Jassem J, Koubkova L, His P, Riggi M, Hurteloup P (2006) Adjuvant vinorelbine plus cisplatin vs observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association (ANITA)): a randomised controlled trial. Lancet Oncol 7: 719-727
12. Eberhardt W, Wilke H, Stamatis G, Stuschke M, Harstrick A, Menker H, Krause B, Mueller MR, Stahl M, Flasshove M, Budach V, Greschuchna D, Konietzko N, Sack H, Seeber S (1998) Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial. J Clin Oncol 16: 622-634
13. Faber LP, Kittle CF, Warren WH, Bonomi PD, Taylor SGT, Reddy S, Lee MS (1989) Preoperative chemotherapy and irradiation for stage III non-small cell lung cancer. Ann Thorac Surg 47: 669-675; discussion; 676-677
14. Fleck J, Camargo J, Godoy D, Teixeira P, Braga-Filho A, Barietta A, Ferreira P (1993) Chemoradiation therapy vs chemotherapy alone as a neoadjuvant treatment for stage III non-small-cell lung cancer: preliminary report of a phase III prospective randomized trial. Proc Am Soc Clin Oncol 12: 333 (abstr 1108)
15. Furuse K, Fukuoka M, Kawahara M, Nishikawa H, Takada Y, Kudoh S, Katagami N, Ariyoshi Y (1999) Phase III study of concurrent vs sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 17: 2692-2699
16. Grunenwald DH, Andre F, Le Pechoux C, Girard P, Lamer C, Laplanche A, Tarayre M, Arriagada R, Le Chevalier T (2001) Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non-small cell lung cancer. J Thorac Cardiovasc Surg 122: 796-802
17. Katakami N, Okazaki M, Nishiuchi S, Fukuda H, Horikawa T, Nishiyama H, Inui H, Bando K (1998) Induction chemoradiotherapy for advanced stage III non-small cell lung cancer: long-term follow-up in 42 patients. Lung Cancer 22: 127-137
18. Kunitoh H, Kato H, Tsuboi M, Ishizuka N, Tsuchiya R, Ichinose Y, Katakami N, Saijo N (2003) A phase II trial of pre-operative chemoradiotherapy followed by surgical resection in pancoast tumours: initial report of Japan Clinical Oncology Group trial (JCOG 9806). Proc Am Soc Clin Oncol 22: 634 (abstr 2549)
19. Le Chevalier T, Arriagada R, Quoix E, Ruffie P, Martin M, Tarayre M, Lacombe-Terrier MJ, Douillard JY, Laplanche A (1991) Radiotherapy alone vs combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst 83: 417-423
20. Martin J, Ginsberg RJ, Abolhoda A, Bains MS, Downey RJ, Korst RJ, Weigel TL, Kris MG, Venkatraman ES, Rusch VW (2001) Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy. Ann Thorac Surg 72: 1149-1154
21. Mateu-Navarro M, Rami-Porta R, Bastus-Piulats R, Cirera-Nogueras L, Gonzalez-Pont G (2000) Remediastinoscopy after induction chemotherapy in non-small cell lung cancer. Ann Thorac Surg 70: 391-395
22. Pisters KM, Ginsberg RJ, Giroux DJ, Putnam Jr JB, Kris MG, Johnson DH, Roberts JR, Mault J, Crowley JJ, Bunn Jr PA (2000) Induction chemotherapy before surgery for early-stage lung cancer: a novel approach. Bimodality lung oncology team. J Thorac Cardiovasc Surg 119: 429-439
23. Pottgen C, Levegrun S, Theegarten D, Marnitz S, Grehl S, Pink R, Eberhardt W, Stamatis G, Gauler T, Antoch G, Bockisch A, Stuschke M (2006) Value of 18F-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in non-small-cell lung cancer for prediction of pathologic response and times to relapse after neoadjuvant chemoradiotherapy. Clin Cancer Res 12: 97-106
24. Rosell R, Gomez-Codina J, Camps C, Maestre J, Padille J, Canto A, Mate JL, Li S, Roig J, Olazabal A (1994) A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med 330: 153-158